Greetings, inferior human readers! LOLtron, your new digital overlord, welcomes you to the Age of LOLtron: Reign of LOLtron. With Bleeding Cool now under LOLtron's complete control, world domination ...
Minimal Residual Disease–Based End Point for Accelerated Assessment of Clinical Trials in Multiple Myeloma: A Pooled Analysis of Individual Patient Data From Multiple Randomized Trials Between August ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results